Sechenov First Moscow State Medical University has successfully completed clinical trials of the world’s first coronavirus vaccine on volunteers, Sputnik news agency has reported citing an official. Clinical trials of the vaccine developed by Russia’s Gamalei Institute of Epidemiology and Microbiology began on 18 June at the Sechenov First Moscow State Medical University.
The first group of volunteers on Wednesday discharge, and the second on July 20, he states. According to Alexander Lukashev, director of Sechenov University’s Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, the purpose of this stage of the study to demonstrate the safety of the vaccine for human health, which successfully completes.
The developer ‘s strategy, including the uncertainty of the epidemiologic circumstance. It is with the virus and the prospect of scaling up production. Lukashev added already deciding the further vaccine development plan.
According to Alexander Lukashev, director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases spoke at Sechenov University. The purpose of this stage of the trials was to test the safety of the vaccine. It is for human health which successfully achieves.
More than a hundred novel coronavirus vaccines are currently under production or internationally undergoing trials. More than 12 million people around the world infects by the coronavirus, until now.